TLR7 Signaling Shapes and Maintains Antibody Diversity Upon Virus-Like Particle Immunization

Virus-like particles (VLPs) are used in different marketed vaccines and are able to induce potent antibody responses. The innate pattern recognition receptors TLR7/8 recognize single stranded (ss) RNA naturally packaged into some VLPs and have been shown to enhance the production of IgG antibodies upon immunization. Here we demonstrate that, upon immunization with RNA-loaded bacteriophage-derived VLP Qβ, TLR7 signaling accelerates germinal center formation, promotes affinity/avidity maturation of VLP-specific IgG and isotype switching to IgG2b/2c. These findings extrapolated to antigens displayed on Qβ; as Fel d 1, the major cat allergen, chemically attached to Qβ also induced higher affinity/avidity IgG2b/2c antibodies in a TLR7-dependent fashion. Chimeric mice lacking TLR7-expression exclusively in B cells demonstrated that the enhanced IgG responses were driven by a B cell intrinsic mechanism. Importantly, deep sequencing of the BCR repertoire of antigen-specific B cells demonstrated higher diversity in mice with TLR7 signaling in B cells, suggesting that TLR7-signaling drives BCR repertoire development and diversity. Furthermore, the current data demonstrate that high levels of clonal diversity are reached early in the response and maintained by TLR7 signaling. In conclusion, TLR7 signaling enhances levels and quality of IgG antibodies, and this finding has major implications for vaccine design.

[1]  M. Vogel,et al.  A scalable and highly immunogenic virus‐like particle‐based vaccine against SARS‐CoV‐2 , 2021, Allergy.

[2]  M. Vogel,et al.  Low‐affinity but high‐avidity interactions may offer an explanation for IgE‐mediated allergen cross‐reactivity , 2021, Allergy.

[3]  M. Vogel,et al.  Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like Particles , 2021, Vaccines.

[4]  M. Vogel,et al.  AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate , 2021, Vaccines.

[5]  M. Vogel,et al.  SARS-CoV-2 structural features may explain limited neutralizing-antibody responses , 2021, NPJ vaccines.

[6]  K. Fitzgerald,et al.  Toll-like Receptors and the Control of Immunity , 2020, Cell.

[7]  M. Vogel,et al.  Vaccination Against Amyloidogenic Aggregates in Pancreatic Islets Prevents Development of Type 2 Diabetes Mellitus , 2020, Vaccines.

[8]  Qingyuan Du,et al.  Candidate , 2012, Juan Perón.

[9]  M. Bachmann,et al.  Type of RNA Packed in VLPs Impacts IgG Class Switching—Implications for an Influenza Vaccine Design , 2019, Vaccines.

[10]  M. Vogel,et al.  Vaccination with nanoparticles combined with micro-adjuvants protects against cancer , 2019, Journal of Immunotherapy for Cancer.

[11]  M. Vogel,et al.  RNA and Toll-Like Receptor 7 License the Generation of Superior Secondary Plasma Cells at Multiple Levels in a B Cell Intrinsic Fashion , 2019, Front. Immunol..

[12]  M. Vogel,et al.  Immunogenicity and Immunodominance in Antibody Responses. , 2019, Current topics in microbiology and immunology.

[13]  M. Vogel,et al.  An unexpected protective role of low‐affinity allergen‐specific IgG through the inhibitory receptor Fc&ggr;RIIb , 2018, The Journal of allergy and clinical immunology.

[14]  Fuping Zhang,et al.  B Cell–Intrinsic MyD88 Signaling Promotes Initial Cell Proliferation and Differentiation To Enhance the Germinal Center Response to a Virus-like Particle , 2018, The Journal of Immunology.

[15]  J. Novák,et al.  Humoral response of mice infected with Toxocara canis following different infection schemes , 2017, Acta Parasitologica.

[16]  R. Maul,et al.  Co-Stimulation of BCR and Toll-Like Receptor 7 Increases Somatic Hypermutation, Memory B Cell Formation, and Secondary Antibody Response to Protein Antigen , 2017, Front. Immunol..

[17]  M. Bachmann,et al.  Major findings and recent advances in virus-like particle (VLP)-based vaccines. , 2017, Seminars in immunology.

[18]  D. Harper,et al.  HPV vaccines - A review of the first decade. , 2017, Gynecologic oncology.

[19]  A. Oxenius,et al.  Dissecting the Contribution of IgG Subclasses in Restricting Airway Infection with Legionella pneumophila , 2014, The Journal of Immunology.

[20]  Jim Euchner Design , 2014, Catalysis from A to Z.

[21]  H. Grönlund,et al.  Mammalian-derived respiratory allergens - implications for diagnosis and therapy of individuals allergic to furry animals. , 2014, Methods.

[22]  M. Matloubian,et al.  B Cell–Intrinsic TLR7 Signaling Is Required for Optimal B Cell Responses during Chronic Viral Infection , 2013, The Journal of Immunology.

[23]  A. DeFranco,et al.  Contribution of Toll‐like receptor signaling to germinal center antibody responses , 2012, Immunological reviews.

[24]  A. Macpherson,et al.  Age, microbiota, and T cells shape diverse individual IgA repertoires in the intestine , 2012, The Journal of experimental medicine.

[25]  R. Coffman,et al.  Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response. , 2011, Immunity.

[26]  C. Loddenkemper,et al.  Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. , 2010, Immunity.

[27]  Martin F. Bachmann,et al.  Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns , 2010, Nature Reviews Immunology.

[28]  T. Kündig,et al.  Mechanisms of allergen-specific desensitization. , 2010, The Journal of allergy and clinical immunology.

[29]  M. Bachmann,et al.  Cutting Edge: IL-21 and TLR Signaling Regulate Germinal Center Responses in a B Cell-Intrinsic Manner , 2010, The Journal of Immunology.

[30]  M. Bachmann,et al.  Isolation of human monoclonal antibodies by mammalian cell display , 2008, Proceedings of the National Academy of Sciences.

[31]  Stephen W. Martin,et al.  Heterogeneous antibody repertoire of marginal zone B cells specific for virus-like particles. , 2007, Microbes and infection.

[32]  A. Jegerlehner,et al.  TLR9 Signaling in B Cells Determines Class Switch Recombination to IgG2a , 2007, The Journal of Immunology.

[33]  J. Coutelier,et al.  Increased Efficacy of the Immunoglobulin G2a Subclass in Antibody-Mediated Protection against Lactate Dehydrogenase-Elevating Virus-Induced Polioencephalomyelitis Revealed with Switch Mutants , 2002, Journal of Virology.

[34]  Ruslan Medzhitov,et al.  Toll-like receptors and innate immunity , 2001, Nature Reviews Immunology.

[35]  P. Pumpens,et al.  Mutilation of RNA phage Qβ virus‐like particles: from icosahedrons to rods , 2000, FEBS letters.

[36]  P. Pumpens,et al.  Recombinant RNA phage Q beta capsid particles synthesized and self-assembled in Escherichia coli. , 1993, Gene.

[37]  A. Denman Cellular and Molecular Immunology , 1992 .

[38]  Asphalt Pavement Mixes,et al.  DEVELOPMENT OF A , 2011 .